Potential cost-effectiveness of a rotavirus immunization program in rural China

Clinical Infectious Diseases

Volumn 49, Issue 8, 2009, Pages 1202-1210

  Wang, Xuan Yi ^a,b,e   Riewpaiboon, Arthorn ^f   Von Seidlein, Lorenz ^e   Chen, Xing Bao ^b   Kilgore, Paul E ^e   Ma, Jing Chen ^c   Qi, Sun Xiang ^c   Zhang, Zhi Yong ^d   Hao, Zhi Yong ^d   Chen, Ji Chao ^d   Xu, Zhi Yi ^e  

^a Institutes of Biomedical Sciences   (China)

^b FUDAN UNIVERSITY   (China)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Zhengding Center for Disease Control and Prevention   (China)

^e International Vaccine Institute   (South Korea)

^f MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ARTICLE; CHILD; CHINA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIARRHEA; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; NEWBORN; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; ROTAVIRUS; RURAL AREA; SENSITIVITY ANALYSIS;

CHILD, PRESCHOOL; CHINA; COST-BENEFIT ANALYSIS; DIARRHEA; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; RURAL POPULATION;

EID: 70349921262     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605632     Document Type: Article

References (45)

1. 1. Wang XY, Du L, von Seidlein L, et al. Occurrence of shigellosis in the young an elderly in rural China: results of a 12-months populationbased surveillance study. Am J Trop Med Hyg 2005; 73:416-422 (Pubitemid 41278722)
2. Yu WL. Survey on the prevention and treatment of diarrhoea in part of regions, China. Zhonghua Liu Xing Bing Xue Za Zhi 1989; 10:257-60.
3. Fischer TK, Bresee JS, Glass Rl. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine 2004; 22(Suppl 1):S49-54.
4. 4. Glass Rl, Bresee JS, Parashar U, et al. Rotavirus vaccines: past, present, and future. Arch Pediatr 2005; 12:844-847 (erratum: Arch Pediatr 2005; 12:1565. (Pubitemid 40724704)
5. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565-572
6. Fang ZY, Wang B, Kilgore PE, et al. Sentinel hospital surveillance for rotavirus diarrhea in the People's Republic of China, August 2001-July 2003. J Infect Dis 2005;192(Suppl 1):S94-9.
7. Sun LW, Tong ZL, Li LH, et al. Surveillance finding on rotavirus in Changchun children's hospital during July 1998-June 2001 [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2003;24:1010-1012
8. Tong ZL, Ma L, Zhang J, et al. Epidemiological study of rotavirus diarrhea in Beijing, China-a hospital-based surveillance from. 1998-2001 [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2003;24:1100-1103
9. Chen DM, Bai ZS, Liu S, et al. Primary study on the reactogenicity and immunogenicity of oral, live rotavirus vaccine (LL-85-37 strains) [in Chinese], Zhongguo Sheng Wu Zhi Ping Xue Za Zi 1994;7:53-56
10. Liu DL, Yang J, Li A. Observation of immunization effect and reverse reaction of rotavirus vaccine [in Chinese]. Zhongguo Ji Hua Mian Yi 2002;8:138-141
11. 11. Hsiao W. The Chinese health care system: lessons for other nations. Soc Sci Med 1995;41:1047-1055 (Pubitemid 26465953)
12. Zheng LS, Zhang Q, Xie HP, et al. Survey on the rotavirus diarrhea in infants in Lulong County, 1999-2000 [in Chinese]. Zhonghua Er Ke Za Zhi 2002; 40:555.
13. Clemens J, Kotloff K, Kay B. Generic protocol to estimate the burden of Shigella diarrhoea and dysenteric mortality. Field test version, May 1999. Department of Vaccines and Biologicals. World Health Organization. Available at: http://www.who.int/vaccines-documents/Docs PDF99/www9947.pdf. Accessed 5 January 2004.
14. World Health Organization (WHO). Generic protocols (i) hospitalbased surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. 2002. Available at: http:// www.path.org/ vaccineresources/details.php?i = 513. Accessed 5 January 2004.
15. Kobelt G. Health economics: an introduction to economic evaluation. 2nd ed. London: Office of Health Economics, 2002.
16. Koopmanschap MA, Rutten FF. A practical guide for calculating indirect costs of disease. Pharmacoeconomics 1996; 10:460-466
17. 17. Riewpaiboon A, Malaroje S, Kongsawatt S. Effect of costing methods on unit cost of hospital medical services. Trop Med Int Health 2007; 12:554-563 (Pubitemid 46631146)
18. Bureau of Statistics, Zhengding County. Statistics on economy in 2004. Zhengding: Bureau of Statistics, Zhengding County, 2005:140.
19. 19. Ruiz Palacios G, Pérez Schael I, Velazquez F, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22. (Pubitemid 43048947)
20. 20. Vesikari T, Matson D, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33. (Pubitemid 43048948)
21. Lu L, Jin S, Yu J, et al. Study on the cost of expanded programme on immunization in areas with different economic levels. Zhonghua Liu Xing Bing Xue Za Zhi 2004;25:684-687
22. Yu W, Cui G, Yu J, Jin S, Wang J, Tao Z. Study on reasonable input of expended program on immunization in some regions of China [in Chinese], Zhongguo Ji Hua Mian Yi 2005; 11:386-391
23. 23. Ding D, Kilgore P, Clemens JD, Wei L, Zhi-Yi X. Cost-effectiveness of rountine immunization to control Japanese encephalitis in Shanghai, China. Bull World Health Organ 2003;81:334-342 (Pubitemid 36644259)
24. Edejer TT-T, Baltussen R, Adam T, et al. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva, Switzerland: World Health Organization, 2003.
25. Wang XY, Xu ZY, von Seidlein L, et al. Incidence of diarrhea caused by rotavirus infections in rural Zhengding, China: prospective, population-based surveillance. J Infect Dis 2005; 192(Suppl 1):S100-5.
26. Torrance GW, Siegel JE, Luce BR. Framing and designing the costeffectiveness analysis. In: Gold MR, Sigel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996:54.
27. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. Oxford: Oxford University Press, 2007.
28. Manning WG, Fryback DG, Weinstein MC. Reflecting uncertainty in cost-effectiveness analysis. In: Gold MR, Sigel JE, Russell LB, Weinstein MC, cds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996:247.
29. Song XB, Tao FB, Ding H, Wang B, Jin H, Gu HY. Etiological study on human rotavirus infection among children under 5 years old with acute diarrhea in two hospitals in Maanshan and Suzhou city [in Chinese], Ji Bing Kong Zhi Za Zhi 2004; 8:342-344
30. Jacobson RM. The current status of the rotavirus vaccine. Vaccine 1999;17:1690-1699
31. Kapikian AZ, Chanock RM. Rotaviruses. In: Fields BN, Knipe DM, Howley PM, eds. Fields virology. 3rd ed. New York: Lippincott-Raven, 1996:1657-1688
32. Pazdiora P, Svecova M. Serologic overview of rotavirus antibodies in children under 2 years of age. Epidemiol Mikrobiol Imunol 1997; 46: 34-35
33. WHO. Research priorities for diarrhoeal disease vaccines: memorandum from a WHO meeting. Bull WHO 1991;69:667-676
34. Clark HF, Glass RI, Offit PA. Rotavirus vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia: WB. Saunders, 1999: 987-1005.
35. 35. Ehlken B, Laubereau B, Karmaus W, et al. Prospective populationbased study on rotavirus disease in Germany. Acta Paediatr 2002; 91: 769-775 (Pubitemid 34876162)
36. Ministry of Health, China. China Health Statistics Yearbook 2005. 1 ed. Beijing: Peking Union Medical College Press, 2005.
37. 37. Fischer TK, Anh DD, Antil L, et al. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 2005;192:1720-1726 (Pubitemid 41587821)
38. 38. Isakbaeva ET, Musabaev E, Antil L, et al. Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine. Vaccine 2007; 25:373-380 (Pubitemid 44856079)
39. 39. Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 2005; 192(Suppl 1):S133-45. (Pubitemid 41193115)
40. Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. New York: Oxford University Press, 2006.
41. Department of Population, Social, Science and Technology Statistics, National Bureau of Statistics of China. China Population Statistics Yearbook 2002. Beijing: China Statistics Press, 2002.
42. Zhang HQ. Discussion and analysis on the cause of death under 5 years of age [in Chinese]. Zhongguo Nong Cun Wei Sheng Shi Ye Guan Li 1997; 17:56.
43. Zhou H, Guo GP, Wang Y, Zhao T. Analysis of cause of death under 5 years of age [in Chinese]. Zhongguo Fu You Bao Jian 2004;20:593.
44. Ministry of Health, China; World Health Organization; United Nations Children's Fund; United Nations Population Fund. Joint review of the maternal and child survival strategy in China. December 2006. Available at: http://www.unicef.org/china/Maternal-and-Child-Survival-Strategy-in-China-ENG. pdf. Accessed 6 June 2006.
45. 45. Wang X, von Seidlein L, Robertson S, et al. A community-based cluster survey on preferences for treatment of diarrhoea and dysentery in Zhengding county, Hebei province, China. J Health Popul Nutr 2004; 22:104-112 (Pubitemid 39199656)